A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
Clinical trial NCT01931943 · UNKNOWN
Trial details
- NCT number
- NCT01931943
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2013-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.